BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 14, 2002
View Archived Issues
IGEN Wins $505M From Roche In Court; Roche Plans To Appeal
Read More
Same Gene Inflicts Both Axonal And Demyelinating Versions Of Charcot-Marie-Tooth Neuropathy
Read More
Antigenics Raises $60M From Shelf For Oncophage Trials
Read More
Novo Ends Deal With Flamel, Flamel Signs Deal With Servier
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More
Dendreon Falls On Provenge Phase III Interim Analysis Results
Poor interim statistical analysis of a Phase III trial of Provenge in prostate cancer patients caused Seattle-based Dendreon Corp.'s stock to dive Friday.
Read More